###begin article-title 0
###xml 21 38 21 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 21 37 <span type="species:ncbi:562">Escherichia coli</span>
Plasmid selection in Escherichia coli using an endogenous essential gene marker
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 590 597 590 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 640 645 640 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 590 597 <span type="species:ncbi:562">E. coli</span>
Antibiotic resistance genes are widely used for selection of recombinant bacteria, but their use risks contributing to the spread of antibiotic resistance. In particular, the practice is inappropriate for some intrinsically resistant bacteria and in vaccine production, and costly for industrial scale production. Non-antibiotic systems are available, but require mutant host strains, defined media or expensive reagents. An unexplored concept is over-expression of a host essential gene to enable selection in the presence of a chemical inhibitor of the gene product. To test this idea in E. coli, we used the growth essential target gene fabI as the plasmid-borne marker and the biocide triclosan as the selective agent.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
The new cloning vector, pFab, enabled selection by triclosan at 1 muM. Interestingly, pFab out-performed the parent pUC19-ampicillin system in cell growth, plasmid stability and plasmid yield. Also, pFab was toxic to host cells in a way that was reversed by triclosan. Therefore, pFab and triclosan are toxic when used alone but in combination they enhance growth and plasmid production through a gene-inhibitor interaction.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI</italic>
The fabI-triclosan model system provides an alternative plasmid selection method based on essential gene over-expression, without the use of antibiotic-resistance genes and conventional antibiotics.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 219 220 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 400 401 400 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 402 403 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
Antibiotic resistance marker genes are commonly used to select and maintain recombinant bacteria in the presence of antibiotics. However, the use of antibiotics is undesirable for manufacturing gene therapy products [1,2]. Also, the introduction of antibiotic resistance genes into biohazardous strains is not recommended [3], and antibiotic selection fails in bacteria that are naturally resistant [3,4]. Finally, the use of antibiotics can be costly in industrial scale production, especially in the case of enzymatic depletion of antibiotic during culture. An alternative system should avoid antibiotic resistance markers and therapeutic antibiotics, be cost effective, but still be convenient, robust and flexible.
###end p 9
###begin p 10
###xml 331 332 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 391 395 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lac </italic>
###xml 510 511 510 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 609 610 609 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 646 647 646 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
A variety of strategies for antibiotic-free selection have been developed, but none are widely used in bacteria. The first reported non-antibiotic system involves an auxotrophic bacterial strain and complementation using a plasmid-encoded biosynthesis gene, such that only transformants grow on defined media lacking the nutrient [5]. Another system is termed repressor-titration, where the lac operator functions as the vector-borne selection marker, which de-represses a modified chromosomal essential gene [6]. A third general approach is to alter the expression of growth essential genes using synthetic [7] or expressed antisense sequences [8]. Unfortunately, these and other existing non-antibiotic systems suffer from a need for mutant host strains or expensive reagents, and in some cases low efficiency.
###end p 10
###begin p 11
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 313 317 313 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI</italic>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 536 544 536 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 545 547 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 548 550 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 768 770 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 892 894 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 895 897 895 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 536 543 <span type="species:ncbi:562">E. coli</span>
It has been observed that over-expression of a growth essential gene results in reduced susceptibility to the gene product inhibitor [9]. Here we considered a strategy based on an essential gene as the plasmid-borne marker and a specific protein level inhibitor as the selective agent. To test the idea, we chose fabI-triclosan as a model combination because it is a well-studied gene-inhibitor pair: FabI (enoyl ACP reductase) catalyzes fatty acid elongation [10] and confers reduced susceptibility to triclosan when over-expressed in E. coli [11,12]; triclosan inhibits FabI through binding at the ACP-enoyl substrate site, forming a stable FabI/NAD+/triclosan ternary complex [13]. In addition, triclosan is a biocide that fulfils the criteria of a non-antibiotic [14]. It is stable, easy to handle, inexpensive and approved for use in many hygiene, household and industrial applications [15,16].
###end p 11
###begin p 12
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 611 613 611 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 614 616 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
Although triclosan is not used as a systemic therapeutic, it is important to consider possible risks associated with new applications. Most importantly, there is concern that triclosan use may contribute to antibiotic resistance [17]; indeed, resistant mutants can be generated in the laboratory [18-20]. However, studies of bacteria in non-laboratory conditions exposed to biocide-concentrations of triclosan did not find a correlation between antibiotic resistance and decreased triclosan susceptibility [21-23]. Regulatory agencies continue to approve the use of triclosan in domestic and clinical products [24,25], and it appears to be a comparatively safe choice as a selection agent.
###end p 12
###begin p 13
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI</italic>
###xml 255 259 255 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI</italic>
In this study, we tested fabI-marker plasmid selection by triclosan and observed efficient and stable selection. The new system out-performed the parent antibiotic system in growth and plasmid production in the presence of triclosan. Cells containing the fabI-marker plasmid displayed toxic effects in the absence of triclosan, suggesting an "addictive" effect, which may aid plasmid containment.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Bacterial strains, plasmids and media
###end title 15
###begin p 16
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 4 11 <span type="species:ncbi:562">E. coli</span>
The E. coli strains used in this study were DH5alpha (Invitrogen), XL1-Blue (Strategene), HB101, BL21 (Strategene) and K12 (Coli Genetics Stock Center, Yale U.). Plasmids were pUC19 (New England Biolabs), pBAD18 and pBAD18s (National Institute of Genetics, Japan). Media were SOC and LB (GIBCOBRL) supplemented with ampicillin (LBA, 100 mug/ml ampicillin, (Sigma)), triclosan (LBT, 1 muM triclosan; Ciba) and arabinose (Sigma). Triclosan was used as a 1 M stock in DMSO.
###end p 16
###begin title 17
Construction of pFab, pUCFA and pBFab
###end title 17
###begin p 18
###xml 3 6 3 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eag</italic>
###xml 111 114 111 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bla</italic>
###xml 234 237 234 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eag</italic>
###xml 359 363 355 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bla </italic>
###xml 396 399 392 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ssp</italic>
###xml 405 408 401 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eag</italic>
###xml 429 434 425 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 619 623 615 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EcoR</italic>
###xml 629 632 625 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eag</italic>
###xml 670 678 666 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 834 837 824 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fab</italic>
###xml 874 877 864 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sph</italic>
###xml 883 886 873 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 1020 1028 1010 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 670 677 <span type="species:ncbi:562">E. coli</span>
###xml 1020 1027 <span type="species:ncbi:562">E. coli</span>
An EagI site was created at nucleotide position 1621 of pUC19 (New England Biolabs), immediately downstream of bla, by PCR with primers (5'cgtcggccgttaccaatgcttaatcag and 5'cgccggccggaccaagtttactcatat). The amplicon was digested with EagI (New England Biolabs), ligated with T4 DNA ligase and transformed into DH5alpha for propagation. To construct pFab, the bla gene was excised from pUC19 with SspI and EagI, and replaced with fabI together with its promoter, which was amplified from K12 genomic DNA using the primers 5'ccggatatcgtgctggagaatattcg and 5'gcgcggccgttatttcagttcgagttcgtt. The amplicon was digested with EcoRV and EagI and used to create the pFab vector. E. coli DH5alpha were transformed with pFab and plated onto LB with 0.5 - 5 muM triclosan. Transformants were subsequently maintained in 1 muM triclosan (LBT). The fabI gene was also cloned into pUC19 at SphI and BamHI within the MCS (pUCFA) in a similar way using the primers 5'ccggcatgcgtgctggagaatattcg and 5'ccggatccgattatttcagttcgagt. Competent E. coli DH5alpha were transformed with pUCFA and plated onto LBA and LBT.
###end p 18
###begin p 19
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 35 38 35 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink">BAD</sub>
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 164 167 164 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 174 177 174 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 287 292 287 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 521 526 521 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 600 608 600 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 600 607 <span type="species:ncbi:562">E. coli</span>
To induce expression of fabI from PBAD, the fabI amplicon generated from primers (5'cggaattcgaatgggttttctttccgg and 5'cctctagagattatttcagttcgagt) was digested with EcoRI and XbaI (New England Biolabs) and cloned into pBAD18s, which was similarly digested, to yield pBFab1. Expression of fabI in pBAD18 required a Shine Dalgarno sequence, which was predicted to be uaagga at position -13 relative to the start codon. Primers (5'cggaattctcaacaataaggattaaagc and 5'cctctagagattatttcagttcgagt) were used for amplification of fabI with its Shine Dalgarno sequence, and cloned into pBAD18 to yield pBFab6. E. coli DH5alpha were transformed with the pBFab plasmids and plated onto LBA, LBT and LBT with 0.2% (w/v) arabinose.
###end p 19
###begin title 20
Plasmid and transformant properties
###end title 20
###begin p 21
Transformation efficiencies of chemically competent DH5alpha cells were determined as recommended by the manufacturer (Invitrogen).
###end p 21
###begin p 22
###xml 193 197 193 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">260 </sub>
###xml 243 246 243 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
Plasmid yields were determined from five clones of pUC19 and pFab. Plasmids were isolated from one ml overnight cultures grown under selection using a miniprep kit (Qiagen) and quantified by OD260 readings. Plasmids (50 ng) were digested with BamHI and electrophoresed in a 1% agarose gel.
###end p 22
###begin p 23
Plasmid stability was assayed either in the presence or absence of selection. Overnight cultures grown under selection at 37degreesC with shaking were diluted 1000 x in 5 ml LB with or without selection, and aliquots of the time zero cultures were diluted and plated onto LB plates containing X-Gal (20 mug/ml, Saveen). The time zero cultures were grown and diluted as above at 24 and 48 h, and aliquots of the 48 h cultures were plated. The ratios of blue colonies to total colonies on LB plates with X-Gal (20 mug/ml) were determined at 0 h and 48 h, from which % plasmid-bearing cells at 48 h were calculated. Five independent clones of pUC19 and pFab were used to provide replicates.
###end p 23
###begin p 24
###xml 737 747 736 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ&#945; </italic>
###xml 799 803 794 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dxs </italic>
###xml 826 828 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 868 878 863 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ&#945; </italic>
###xml 882 886 873 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dxs </italic>
###xml 1177 1191 1168 1174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-&#916;&#916;CT </sup>
###xml 1217 1219 1200 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1268 1272 1251 1255 <sub xmlns:xlink="http://www.w3.org/1999/xlink">260 </sub>
Plasmid abundance was determined in two ways. First, to compare band intensities of genomic (gDNA) to plasmid DNA (pDNA) in an agarose gel, total genomic DNA was extracted from five different clones of pUC19 and pFab clones grown under selection for 16 h. Five cultures of K12, derived from five single colonies, were grown in LB for DNA extraction using the Bacterial GenElute system (Sigma) for one ml of overnight culture. Total DNA (10 mul) was electrophoresed in a 1% agarose gel, stained with ethidium bromide and scanned using a Typhoon 9400 (Amersham Biosciences). Band intensities were determined by using ImageQuant software (Amersham Biosciences). Second, relative quantitative PCR (qPCR) was carried out by using the plasmid lacZalpha gene as the target gene and single copy chromosomal dxs as the reference gene [26]. K12 gDNA containing a single copy of lacZalpha and dxs was used as a calibrator. Primers amplifying the target gene (5'gtgctgcaaggcgattaagtt and 5' cactggccgtcgttttacaa), and reference gene (5'cgagaaactggcgatcctta and 5'cttcatcaagcggtttcaca) were validated for similar amplification efficiencies. Real time data analyses were carried out by the 2-DeltaDeltaCT method for relative qPCR [27]. Total DNA concentrations were determined by OD260 absorbance for qPCR. Each 25 mul of PCR reaction contained 12.5 mul of SYBR Green PCR buffer (Eurogentec), 100 nM of each primer (Biomers) and 5 ng total DNA.
###end p 24
###begin p 25
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 107 111 107 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink">550 </sub>
###xml 223 227 223 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink">550 </sub>
###xml 256 258 256 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 375 379 374 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink">550 </sub>
Growth rates were calculated from the exponential phase of growth [28], which was monitored as increased OD550 over time by the VERSAmax spectrophotometer (Molecular Devices). An overnight culture (16 h), standardized by OD550 to yield approximately 7 x 105 cfu/ml, was grown in 200 mul volumes per well in a 96-well plate for 24 h with agitation for 5 s every 5 min, when OD550 readings were taken. Triclosan was added to give 0 - 2 muM Triclosan and 1% DMSO final concentration.
###end p 25
###begin p 26
###xml 44 52 44 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 279 282 279 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 44 51 <span type="species:ncbi:562">E. coli</span>
The host range of pFab within commonly used E. coli cloning strains was tested by transformation of XL1-Blue (Stratagene), HB101 and BL21, followed by selection on LBT plates. Plasmid DNA integrity and abundance was determined by plasmid extraction, digestion of 100 ng DNA with BamHI and fractionation in a 1% agarose gel.
###end p 26
###begin title 27
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI</italic>
Inducible expression of fabI
###end title 27
###begin p 28
###xml 91 93 91 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 483 487 481 485 <sub xmlns:xlink="http://www.w3.org/1999/xlink">550 </sub>
Clones of pBFab1 and pBFab6 were grown in LBA for 16 h, diluted to approximately 5 - 9 x 106 cfu/ml in LBT and aliquots of 180 mul were added to wells in a 96 well plate. Arabinose was added to a final concentration of 0 - 5% and the final volume per well was made up to 200 mul with water. Clones of pBAD18 and pBAD18s were included as controls. Cultures were grown for 24 h in the VERSAmax spectrophotometer (Molecular Devices) with agitation for 5 s every 5 min, followed by an OD550 reading. The growth rate at each arabinose concentration was calculated as described above.
###end p 28
###begin title 29
Cell viability
###end title 29
###begin p 30
###xml 170 172 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
DH5alpha/pFab were grown overnight in the absence or presence of 0.5 - 2 muM triclosan and subjected to SYTOX green staining and flow cytometry, as previously described [29]. DH5alpha/pUC19 was included as a control to determine staining levels of live and heat-treated dead cells. Samples were excited with a 488 nm air-cooled argon ion laser in the CyFlow SL flow cytometer (Partec GmbH). Threshold settings were enabled on forward scatter to exclude cell debris. The forward and side scatter dot plot was used to identify and gate cell populations. Fluorescence was measured at 520 nm. Viable and dead cell populations were counted using the Partec, FloMax software version 2.4e.
###end p 30
###begin title 31
Growth competition
###end title 31
###begin p 32
###xml 123 125 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
Growth competition between DH5alpha and plasmid bearing cells was carried out as previously described, with modifications [30]. Overnight (24 h) cultures of DH5alpha, DH5alpha/pUC19 and DH5alpha/pFab were prepared in LB, LBA and LBT, respectively. Equal volumes of DH5alpha and plasmid bearing cultures were mixed and diluted 1:100 in 10 ml fresh LB for further growth. An aliquot of the diluted mixed culture was simultaneously plated onto selective and non-selective media for cell counts. After the mixed culture was incubated for 24 h with shaking at 37degreesC, it was diluted 1:100 in 10 ml of fresh LB for further growth and plated, as above. This procedure was repeated 5 times over six days. The numbers of ampicillin or triclosan resistant colonies were scored relative to the total CFUs.
###end p 32
###begin title 33
Results
###end title 33
###begin title 34
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
Vectors containing fabI enable triclosan selection
###end title 34
###begin p 35
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 148 153 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 228 231 228 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bla</italic>
###xml 342 347 342 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 395 403 395 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 570 575 566 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 786 788 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 976 980 972 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI</italic>
###xml 395 402 <span type="species:ncbi:562">E. coli</span>
To test the potential of fabI as a selective marker for cloning, two vectors derived from pUC19 were constructed. First, we constructed pFab, where fabI together with its native promoter replaces the ampicillin resistance gene (bla) in pUC19. Second, to enable selection with triclosan or ampicillin, we constructed pUCFA, which contains the fabI cassette cloned into the pUC19 MCS (Figure 1A). E. coli strain DH5alpha was transformed with pFab, pUCFA or pUC19 and transformants were selected on LB plates containing triclosan (LBT) or ampicillin (LBA). As anticipated, fabI inserts enabled selection on triclosan containing plates. Colonies formed on LBT were more variable in size than colonies on LBA. However, triclosan-resistant colonies of all sizes maintained resistance (Figure 1B) and displayed uniform colony morphologies upon re-plating. In contrast to pUC19, we did not observe plasmid-free colonies or satellite colonies when using pFab and pUCFA. Therefore, the fabI-triclosan system enables non-antibiotic selection and maintains stable recombinant strains.
###end p 35
###begin p 36
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Vector construction and triclosan selection</bold>
###xml 46 47 46 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bla </italic>
###xml 127 132 127 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 223 226 223 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 231 235 231 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hind</italic>
###xml 243 246 243 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pst</italic>
###xml 276 281 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 357 360 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aat</italic>
###xml 367 371 367 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AlwN</italic>
###xml 396 401 396 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 513 514 513 514 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 572 573 572 573 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 608 616 608 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 641 644 641 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 608 615 <span type="species:ncbi:562">E. coli</span>
Vector construction and triclosan selection. (A) The bla gene in pUC19, which confers ampicillin resistance, was replaced with fabI and its promoter region (pFab). The pUC19 multiple cloning site (MCS) is retained, however HincII, HindIII and PstI are not unique in pFab. The fabI cassette in pFab can be transferred to other pUC-derived plasmids using the AatII and AlwNI restriction sites. The fabI cassette was also inserted into the MCS of pUC19 to obtain pUCFA. All plasmids are available from the authors. (B) Growth of pFab and pUCFA clones on LBT and LBA plates. (C) Plasmids propagated in different E. coli hosts were digested with BamHI and analyzed by gel electrophoresis.
###end p 36
###begin p 37
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI</italic>
###xml 70 78 70 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 257 259 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 278 283 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 591 595 587 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI</italic>
###xml 670 678 666 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 70 77 <span type="species:ncbi:562">E. coli</span>
###xml 670 677 <span type="species:ncbi:562">E. coli</span>
To test whether fabI-triclosan selection could function well in other E. coli strains, pFab was transformed into strains BL21, HB101 and XL1-blue. Similar to the results in DH5alpha, we observed efficient selection and high yield plasmid production (Figure 1C). To test whether fabI can enable triclosan selection in other vectors, the pFab cassette was inserted into the multiple cloning site of pGEM-3Zf and also used to replace the ampicillin resistance gene in the low copy number vector pBR322. In both cases, triclosan resistant colonies were selected (data not shown). Therefore, the fabI-triclosan system enables efficient selection in commonly used vectors and E. coli strains.
###end p 37
###begin p 38
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 154 159 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 196 200 196 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink">BAD </sub>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 322 327 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 503 504 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 580 584 580 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI</italic>
To confirm that fabI expression was the main mechanism mediating triclosan resistance and not point mutations within chromosomal fabI [12], expression of fabI was placed under the control of the PBAD promoter in pBAD18s (pBFab1) and pBAD18 (pBFab6) [31]. The pBFab1 and pBFab6 strains were tested for resistance following fabI induction. In the absence of the inducer arabinose, no growth was observed in LBT broth, but growth rates increased with increasing arabinose concentrations up to 0.4% (Figure 2). Therefore, pFab-mediated resistance to triclosan is due to expression of fabI.
###end p 38
###begin p 39
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of <italic>fabI </italic>induction on triclosan resistance</bold>
###xml 120 124 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI</italic>
Effect of fabI induction on triclosan resistance. Triclosan resistance mediated by arabinose-induced over-expression of fabI. Exponential growth rates are for DH5alpha/pBFab1 and DH5alpha/pBFab6 relative to DH5alpha/pBAD18s and DH5alpha/pBAD18, respectively.
###end p 39
###begin title 40
Characterization of pFab
###end title 40
###begin p 41
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 237 238 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 243 251 243 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 413 414 409 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 423 425 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 243 250 <span type="species:ncbi:562">E. coli</span>
After selection of pFab transformants with triclosan, we characterized the general properties of pFab as a cloning vector, with pUC19 included for comparison (Table 1). Plasmid preparation yield of pFab was 43% greater than pUC19 (Table 1) in E. coli DH5alpha transformants. Also, the copy number of pFab was 38% and 40% greater than that of pUC19, as measured by qPCR and plasmid to genomic DNA abundance (Table 1; Figure 3A & B), respectively. Therefore, pFab displayed higher yield and copy number relative to the parent vector.
###end p 41
###begin p 42
###xml 0 40 0 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Plasmid production of pFab transformants</bold>
###xml 43 44 43 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 266 267 266 267 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 318 319 318 319 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
Plasmid production of pFab transformants. (A) Agarose gel electrophoresis of total DNA isolated from five clones of pUC19 and pFab. Bands were quantified by using ImageQuant software to calculate ratio of pDNA to gDNA as a measure of copy number in pUC19 and pFab. (B) Mean ratios of pDNA:gDNA of pUC19 and pFab from (A).
###end p 42
###begin p 43
Properties of pFab and pUC19
###end p 43
###begin p 44
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
a Determined from five replicate cultures.
###end p 44
###begin p 45
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
b In chemically competent DH5alpha cells.
###end p 45
###begin p 46
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
###xml 59 63 59 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink">260 </sub>
c Plasmid yield from 1 ml of 18 h culture, determined by OD260 absorbance.
###end p 46
###begin p 47
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d </sup>
###xml 36 46 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ&#945; </italic>
###xml 49 53 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dxs </italic>
d Determined from the copy ratio of lacZalpha to dxs by qPCR.
###end p 47
###begin p 48
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">e </sup>
e Percentage of plasmid-bearing cells at 48 h in cultures grown with selection.
###end p 48
###begin p 49
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f </sup>
f Percentage of plasmid-bearing cells at 48 h in cultures grown without selection.
###end p 49
###begin p 50
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g </sup>
###xml 14 18 14 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink">550 </sub>
g Change in OD550 over time of DH5alpha/pUC19 cultures in LB and DH5alpha/pFab in LB or LBT, relative to control DH5alpha/pUC19 cultures in LBA.
###end p 50
###begin p 51
###xml 503 504 499 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
To assess plasmid stability, we first scored the number of triclosan resistant colony forming units relative to total colony forming units. Surprisingly, we observed more colonies on LBT than on LB plates. This indicated high plasmid stability in the presence of triclosan, but some form of pFab-mediated toxicity in the absence of triclosan. Indeed, measurements of plasmid stability using an alternative alpha-complementation assay revealed that pFab was more stable than pUC19 under selection (Table 1). Therefore, while pFab over-expression clearly conferred triclosan resistance, it also appeared to confer a requirement for the biocide.
###end p 51
###begin title 52
###xml 33 41 33 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 33 40 <span type="species:ncbi:562">E. coli</span>
Effects of pFab and triclosan on E. coli growth, survival and fitness
###end title 52
###begin p 53
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 439 441 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 449 450 433 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 911 913 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 1077 1079 1051 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1311 1313 1284 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1459 1461 1432 1434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
To further investigate the interaction between fabI and triclosan, we first examined culture growth profiles. While ampicillin had little effect on DH5alpha/pUC19 cultures, the final optical density of DH5alpha/pFab was highest in the presence of triclosan and the exponential phase growth rates of DH5alpha/pFab cultures were faster than DH5alpha/pUC19 cultures under selection, whereas the inverse was observed without selection (Figure 4A; Table 1). We next determined DH5alpha/pFab culture growth rates in the presence of a range of triclosan concentrations (0 - 2 muM). As pFab was unstable without triclosan, DH5alpha/pUCFA grown in LBA was included to prevent the growth of competing plasmid-free cells. Growth rates of pUCFA and pFab clones were lowest without triclosan and increased with triclosan addition up to 1 muM, indicating a triclosan-dependent fitness rescue in cells that carry pFab (Figure 4B). Similarly, we observed that the proportion of dead cells decreased with increasing triclosan concentrations. Fluorescence microscopy of the SYTOX stained cells [29] revealed elongated and dead cells in the absence of triclosan, and elongated and viable cells in 1 muM triclosan (data not shown). The ratio of live to dead cells indicated by SYTOX staining was then quantified by flow cytometry [29]. The results again showed that triclosan reduced the number of dead cells, indicating that pFab transformants were rescued by triclosan (Figure 4C). Therefore, pFab is toxic but this toxicity is suppressed by triclosan.
###end p 53
###begin p 54
###xml 0 71 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of triclosan on growth, viability and fitness pFab transformants</bold>
###xml 74 75 74 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 250 251 242 243 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 274 279 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 448 449 436 437 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 623 624 607 608 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
Effect of triclosan on growth, viability and fitness pFab transformants. (A) Growth curves for DH5alpha/pUC19 and DH5alpha/pFab cultures grown with and without selection. Growth rates were determined from the exponential phase, indicated by arrows. (B) Reduced fitness with fabI over-expression and its suppression by triclosan. Growth rates of pFab and pUCFA clones in LB and LBA, respectively, were calculated relative to DH5alpha/pUC19 in LBA. (C) Flow cytometric determination of dead cell numbers, as a measure of cell toxicity, in DH5alpha/pFab cultures grown in the presence of a range of triclosan concentrations. (D) Growth competition between DH5alpha and DH5alpha/pUC19 or DH5alpha/pFab. The log10 ratio of plasmid-bearing cells to total number of cells against time represents the rate of plasmid loss in mixed cell populations. The data is representative of two independent experiments.
###end p 54
###begin p 55
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
To test whether triclosan resistance is likely to persist outside intended applications, we assessed the fitness of DH5/pUC19 and DH5/pFab strains in mixed culture with the plasmid-free parent strain. A competitive fitness assay, conducted in the absence of selection, showed that pFab persistence was weaker than that of pUC19 during co-culture over six days (Figure 4D). In other words, the rate of pFab loss was faster than pUC19 loss and therefore, in the absence of selection, pFab is less stable and less competitive than pUC19.
###end p 55
###begin title 56
Discussion
###end title 56
###begin p 57
###xml 142 149 142 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 157 162 157 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 707 709 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 837 839 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 840 842 840 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 857 859 857 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 142 149 <span type="species:ncbi:562">E. coli</span>
We describe over-expression of a growth essential gene conferring resistance to a specific protein inhibitor as a plasmid selection system in E. coli, using fabI and triclosan as an example. As well as avoiding the use of antibiotic resistance genes and antibiotics, pFab transformants showed improved growth, yield and gene containment. These improvements appear to be due to the mechanism of inhibition [13] and a balance of toxic gene-inhibitor levels required for cell survival [32] and selection [33]. Similar interactions in other systems suggest that gene-inhibitor reciprocal suppression may be a common mechanism. For example, reciprocal or mutual suppression has been described between two genes [34] and chemical inhibitors [35]. Also, antibiotic-dependent strains have been described for bacteria isolated from laboratories [36,37] and clinics [38].
###end p 57
###begin p 58
###xml 49 57 49 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 495 503 495 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 608 613 608 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 798 803 798 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI </italic>
###xml 811 812 811 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 855 863 855 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 957 958 957 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1061 1063 1061 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1064 1066 1064 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1115 1117 1115 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1152 1154 1152 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1155 1157 1155 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1158 1160 1158 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1204 1206 1204 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1539 1541 1539 1541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1598 1600 1598 1600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1601 1603 1601 1603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 49 56 <span type="species:ncbi:562">E. coli</span>
###xml 495 502 <span type="species:ncbi:562">E. coli</span>
###xml 855 862 <span type="species:ncbi:562">E. coli</span>
The new selection system relies on an endogenous E. coli gene and a widely used biocide. Nevertheless, the relative safety of triclosan and fabI in this application should be considered. Triclosan is approved by regulatory authorities in the EU and the USA for many applications [24,25] and an association between bacterial triclosan resistance and antibiotic susceptibility, though suggested, has not been found in practice [21-23,39,40]. In the laboratory, spontaneous triclosan resistance in E. coli resulting from exposure to low triclosan concentration has been observed, where three point mutations in fabI increased MIC by up to 95 fold [12]. Such mutations may arise during triclosan selection. However, in our experiments, triclosan resistance was dependent on expression of plasmid-borne fabI (Figure 2), and blue-white selection of recombinant E. coli indicated mostly pFab-carrying cells (blue) and very few spontaneous resistant mutants (Table 1). In the environment, triclosan resistance has been slow to emerge compared to antibiotic resistance [21,23], possibly due to poor solubility of triclosan [41], rapid degradation of triclosan [22,42,43], low competitive fitness of FabI mutants [12], and the tripartite nature of the FabI/NADPH/triclosan complex. Furthermore, the spread of pFab outside of intended applications should be limited due to low plasmid stability, poor competitive fitness and cell toxicity in the absence of triclosan. Indeed, FabI is stringently regulated within the fatty acid biosynthesis pathway [32], and de-regulation inhibits cell growth and viability [44,45]. Nevertheless, it is possible that pFab could transfer horizontally and thus induce resistance to triclosan in wild-type bacteria, and standard precautions in the handling of genetically modified microorganisms should be maintained.
###end p 58
###begin p 59
In large scale production of proteins, plasmid stability without selection is a pre-requisite because residual antibiotics are undesirable. In this regard, the finding that pFab requires triclosan for plasmid stability could be a disadvantage. However, the amount of triclosan required is much less compared to that in antibiotic selection (typically 2%), and a level of residual triclosan may be permissible, given its approval for use in non-prescription medicines and hygiene products. Therefore, the need for stability in the absence of selection may prove less important with this system. Nevertheless, pFab stability is a potential problem and vector construct or process adjustments may be needed during scale-up.
###end p 59
###begin title 60
Conclusion
###end title 60
###begin p 61
###xml 243 265 243 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus </italic>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 274 298 274 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium smegmatis </italic>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 604 622 604 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus subtilis </italic>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 638 663 638 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pneumoniae </italic>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 743 766 743 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas aeruginosa </italic>
###xml 767 769 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 793 797 793 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabI</italic>
###xml 243 264 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 274 297 <span type="species:ncbi:1772">Mycobacterium smegmatis</span>
###xml 604 621 <span type="species:ncbi:1423">Bacillus subtilis</span>
###xml 638 662 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 664 668 <span type="species:ncbi:1313">FabK</span>
###xml 743 765 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
In summary, this study provides an example of how essential genes can be used in combination with non-antibiotic inhibitors to select and maintain recombinant bacteria. It may be possible to apply triclosan selection to other bacteria such as Staphylococcus aureus [46] and Mycobacterium smegmatis [47], which have homologues of FabI. Other inhibitors of FabI have been described [48,49] and, depending on bacterial resistance development, certain triclosan analogues may be preferred for use in this plasmid selection system. On the other hand, bacteria that have divergent enoyl-ACP reductase, such as Bacillus subtilis (FabL) [50] and Streptococcus pneumoniae (FabK) [51], and species that are intrinsically resistant to triclosan, such as Pseudomonas aeruginosa [18], are not suitable for fabI-triclosan plasmid selection. For such species, it would be interesting to test additional essential gene inhibitor combinations to expand the plasmid selection strategy described here. The pFab and triclosan system is potentially attractive for production of recombinant proteins, because it can be used to increase plasmid copy number and yield. In addition, pFab and its derivatives may be suitable for manufacturing biopharmaceuticals and gene therapy products, and in other applications that require an absence of antibiotic resistance sequences or antibiotic residues.
###end p 61
###begin title 62
Authors' contributions
###end title 62
###begin p 63
SG carried out all experimental work and data analyses except for flow cytometry, participated in design of study and drafted the manuscript. LG conceived the study, carried out flow cytometry and FACS analysis, and helped with design and drafting the manuscript. All authors have read and approved the final manuscript.
###end p 63
###begin title 64
Acknowledgements
###end title 64
###begin p 65
We thank the Swedish Institute for a Guest Scholarship for SG and the Swedish Research Council and University of London Central Research Fund for support. We also thank Thomas Bentin, Omid Faridani, Abbas Nikravesh, Monica Marta, Joshua Fink and Rikard Dryselius for help and comments.
###end p 65
###begin article-title 66
Points to consider in the production and testing of new drugs and biologicals produced by recombinant DNA technology
###end article-title 66
###begin article-title 67
Validation of growth-based rapid microbiological methods for sterility testing of cellular and gene therapy products
###end article-title 67
###begin article-title 68
Biosafety and selectable markers
###end article-title 68
###begin article-title 69
The neglected intrinsic resistome of bacterial pathogens
###end article-title 69
###begin article-title 70
###xml 67 91 67 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 67 91 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Cloning of a DNA sequence that complements glutamine auxotrophy in Saccharomyces cerevisiae
###end article-title 70
###begin article-title 71
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 0 16 <span type="species:ncbi:562">Escherichia coli</span>
Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration
###end article-title 71
###begin article-title 72
Antibiotic-free bacterial strain selection using antisense peptide nucleic acid
###end article-title 72
###begin article-title 73
A novel antibiotic free plasmid selection system: advances in safe and efficient DNA therapy
###end article-title 73
###begin article-title 74
###xml 12 28 12 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 12 28 <span type="species:ncbi:562">Escherichia coli</span>
An array of Escherichia coli clones over-expressing essential proteins: a new strategy of identifying cellular targets of potent antibacterial compounds
###end article-title 74
###begin article-title 75
###xml 65 81 65 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 65 81 <span type="species:ncbi:562">Escherichia coli</span>
Protein EnvM is the NADH-dependent enoyl-ACP reductase (FabI) of Escherichia coli
###end article-title 75
###begin article-title 76
Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis
###end article-title 76
###begin article-title 77
Triclosan targets lipid synthesis
###end article-title 77
###begin article-title 78
Mechanism of triclosan inhibition of bacterial fatty acid synthesis
###end article-title 78
###begin article-title 79
Biocide use and antibiotic resistance: the relevance of laboratory findings to clinical and environmental situations
###end article-title 79
###begin article-title 80
Advanced oral antibacterial/anti-inflammatory technology: A comprehensive review of the clinical benefits of a triclosan/copolymer/fluoride dentifrice
###end article-title 80
###begin article-title 81
Antiseptic efficacy of a low-dosed topical triclosan/chlorhexidine combination therapy in atopic dermatitis
###end article-title 81
###begin article-title 82
Antibacterial cleaning and hygiene products as an emerging risk factor for antibiotic resistance in the community
###end article-title 82
###begin article-title 83
###xml 54 76 54 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas aeruginosa</italic>
###xml 54 76 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ
###end article-title 83
###begin article-title 84
###xml 35 54 35 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Salmonella enterica</italic>
###xml 59 75 59 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 35 54 <span type="species:ncbi:28901">Salmonella enterica</span>
###xml 59 75 <span type="species:ncbi:562">Escherichia coli</span>
Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents
###end article-title 84
###begin article-title 85
###xml 23 42 23 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Salmonella enterica</italic>
###xml 23 62 <span type="species:ncbi:90371">Salmonella enterica serovar Typhimurium</span>
Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasiveness
###end article-title 85
###begin article-title 86
Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers
###end article-title 86
###begin article-title 87
Exposure of sink drain microcosms to triclosan: population dynamics and antimicrobial susceptibility
###end article-title 87
###begin article-title 88
###xml 76 96 <span type="species:ncbi:1352">Enterococcus faecium</span>
Antibiotic and Disinfectant Susceptibility Profiles of Vancomycin-Resistant Enterococcus faecium (VRE) Isolated from Community Wastewater in Texas
###end article-title 88
###begin article-title 89
Opinion on triclosan resistance
###end article-title 89
###begin article-title 90
Drug approvals
###end article-title 90
###begin article-title 91
###xml 68 84 68 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 68 84 <span type="species:ncbi:562">Escherichia coli</span>
Absolute and relative QPCR quantification of plasmid copy number in Escherichia coli
###end article-title 91
###begin article-title 92
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
###end article-title 92
###begin article-title 93
Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genes
###end article-title 93
###begin article-title 94
Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain
###end article-title 94
###begin article-title 95
Genetic analysis of a plasmid-encoded, host genotype-specific enhancement of bacterial fitness
###end article-title 95
###begin article-title 96
Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter
###end article-title 96
###begin article-title 97
###xml 83 99 83 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 83 99 <span type="species:ncbi:562">Escherichia coli</span>
Regulation of fatty acid elongation and initiation by acyl-acyl carrier protein in Escherichia coli
###end article-title 97
###begin article-title 98
Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan
###end article-title 98
###begin article-title 99
###xml 97 113 97 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 97 113 <span type="species:ncbi:562">Escherichia coli</span>
Mutual suppression of mukB and seqA phenotypes might arise from their opposing influences on the Escherichia coli nucleoid structure
###end article-title 99
###begin article-title 100
Mutual Suppression of the Uricosuric Effects of Sulfinpyrazone and Salicylate: a Study in Interactions between Drugs
###end article-title 100
###begin article-title 101
###xml 42 58 42 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 42 58 <span type="species:ncbi:562">Escherichia coli</span>
Reversion from erythromycin dependence in Escherichia coli: strains altered in ribosomal sub-unit association and ribosome assembly
###end article-title 101
###begin article-title 102
###xml 97 118 97 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 97 118 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Identification and phenotypic characterization of a beta-lactam-dependent, methicillin-resistant Staphylococcus aureus strain
###end article-title 102
###begin article-title 103
###xml 21 42 21 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Enterococcus faecalis</italic>
###xml 21 42 <span type="species:ncbi:1351">Enterococcus faecalis</span>
Vancomycin-dependent Enterococcus faecalis clinical isolates and revertant mutants
###end article-title 103
###begin article-title 104
Relationship between triclosan and susceptibilities of bacteria isolated from hands in the community
###end article-title 104
###begin article-title 105
Common therapeutic approaches for the control of oral biofilms: microbiological safety and efficacy
###end article-title 105
###begin article-title 106
Aquatic toxicity of triclosan
###end article-title 106
###begin article-title 107
Fate and effects of triclosan in activated sludge
###end article-title 107
###begin article-title 108
Photolytic degradation of triclosan in freshwater and seawater
###end article-title 108
###begin article-title 109
###xml 29 45 29 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 29 45 <span type="species:ncbi:562">Escherichia coli</span>
The unmodified (apo) form of Escherichia coli acyl carrier protein is a potent inhibitor of cell growth
###end article-title 109
###begin article-title 110
###xml 93 109 93 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 93 109 <span type="species:ncbi:562">Escherichia coli</span>
Overproduction of a functional fatty acid biosynthetic enzyme blocks fatty acid synthesis in Escherichia coli
###end article-title 110
###begin article-title 111
###xml 18 39 18 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 18 39 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene
###end article-title 111
###begin article-title 112
###xml 30 53 30 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium smegmatis</italic>
###xml 30 53 <span type="species:ncbi:1772">Mycobacterium smegmatis</span>
Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan
###end article-title 112
###begin article-title 113
1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI)
###end article-title 113
###begin article-title 114
Inhibitors of FabI, an Enzyme Drug Target in the Bacterial Fatty Acid Biosynthesis Pathway
###end article-title 114
###begin article-title 115
A triclosan-resistant bacterial enzyme
###end article-title 115
###begin article-title 116
###xml 20 44 20 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pneumoniae</italic>
###xml 20 44 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 85 89 <span type="species:ncbi:1313">FabK</span>
Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK)
###end article-title 116

